Background Potential inappropriate prescribing (PIP) among older persons is a global public health issue. However, trans-country data that can influence interventions on a global or regional level is scarce. Objectives To compare the prevalence of PIP and to determine the associated factors among older Nigerians and South Africans. Settings Nigerian and South African teaching hospitals. Method A retrospective evaluation of randomly selected medical charts of older persons was carried out in outpatient clinics of one University teaching hospital in both Nigeria and South Africa. Older persons aged ≥ 60 years who attended the hospitals’ clinics between 1st January and 31st December 2016 and received medicine prescriptions were included. The PIP was evaluated using the 2015 American Geriatrics Society-Beers Criteria. The prevalence of PIP in both countries was compared and the associated factors for their occurrence determined using a binary logistic regression. Main outcome measure Prevalence of PIP and associated factors among older outpatients. Results A total of 680 participants were evaluated, 352 in Nigeria, mean age 69.03 (7.35) years, and 328 in South Africa, mean age 68.21 (7.42) years (95% CI − 0.28 to 1.94, p = 0.14). The PIP among Nigerian and South African participants were (124/352; 35.2%) versus (97/328; 29.6%) respectively (OR 0.77, 95% CI 0.56–1.06, p = 0.12). Hypertension was significantly associated with PIP among the Nigerians (OR 2.56, 95% CI 1.57–4.17, p = < 0.001) and South Africans (OR 3.11, 95% CI 1.17–8.24, p = 0.02) in a logistic regression. Conclusions The prevalence and pattern of PIP among Nigerian and South African participants were similar. Hypertension was an associated factor for PIP among the participants in both countries.
Beers Criteria Inappropriate prescribing Nigeria Older persons Potentially inappropriate prescribing South Africa
This is a preview of subscription content, log in to check access.
We would like to thank the management and staff of the study sites for their cooperation.
This study received no funding from any source.
Conflicts of interest
The authors declare that no conflict of interest exists in the study.
Nam YS, Han JS, Kim JY, Bae WK, Lee K. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study. BMC Geriatr. 2016;16:118.CrossRefGoogle Scholar
van Heerden JA, Burger JR, Gerber JJ. Inappropriate medicine prescribing in older South Africans: a cross-sectional analysis of medicine claims data. S Afr Med J. 2016;106(10):1010–6.CrossRefGoogle Scholar
Fadare JO, Desalu OO, Obimakinde AM, Adeoti AO, Agboola SM, Aina FO. Prevalence of inappropriate medication prescription in the elderly in Nigeria: a comparison of Beers and STOPP criteria. Int J Risk Saf Med. 2015;27(4):177–89.CrossRefGoogle Scholar
van der Stelt CAK, Vermeulen Windsant-van den Tweel AMA, Egberts ACG, van den Bemt PMLA, Leendertse AJ, Hermens WAJJ, et al. The association between potentially inappropriate prescribing and medication-related hospital admissions in older patients: a nested case control study. Drug Saf. 2016;39(1):79–87.CrossRefGoogle Scholar
American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRefGoogle Scholar
Gallagher P, Ryan C, Byrne S, Kennedy J, Oahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefGoogle Scholar
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–51.Google Scholar
Eze UIH, Olowu AO. Prescribing patterns and inappropriate use of medications in elderly outpatients in a tertiary hospital in Nigeria. Trop J Pharm Res. 2011;10(1):19–25.CrossRefGoogle Scholar
Mekonnen AB, Bhagavathula AS. Inappropriate medication use in the elderly population attending Gondar University Hospital: a preliminary assessment. Int J Pharm Pharm Sci. 2014;6(10):540–3.Google Scholar
Sheikh-Taha M, Dimassi H. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovasc Disord. 2017;17:189.CrossRefGoogle Scholar
Rakesh KB, Chowta MN, Shenoy AK, Shastry R, Pai SB. Evaluation of polypharmacy and appropriateness of prescription in geriatric patients: a cross-sectional study at a tertiary care hospital. Indian J Pharmacol. 2017;49(1):16–20.Google Scholar
Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34.CrossRefGoogle Scholar
Kalusopa TDR, Osei-Boateng C. Social protection schemes in Africa. Windhoek: African Labour Research Network; 2012.Google Scholar
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121–6.CrossRefGoogle Scholar
Levy H, Marcus E, Christen C. Beyond the Beers Criteria: a comparative overview of explicit criteria. Ann Pharmacother. 2010;44(12):1968–75.CrossRefGoogle Scholar
Lim YJ, Kim HY, Choi J, Lee JS, Ahn AL, Oh EJ, et al. Potentially inappropriate medications by Beers Criteria in older outpatients: prevalence and risk factors. Korean J Fam Med. 2016;37(6):329–33.CrossRefGoogle Scholar
Narayan SW, Nishtala PS. Prevalence of potentially inappropriate medicine use in older New Zealanders: a population-level study using the updated 2012 Beers Criteria. J Eval Clin Pract. 2015;21(4):633–41.CrossRefGoogle Scholar
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron P, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–73.CrossRefGoogle Scholar
Dworkin RH, O’Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013;154(11):2249–61.CrossRefGoogle Scholar
Hanlon JT, Semla TP, Schmader KE. Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63(12):e8–18.CrossRefGoogle Scholar
Lopez LM, de Figueiredo TP, Costa SC, Reis AMM. Use of potentially inappropriate medications by the elderly at home. Ciênc saúde coletiva. 2016;21(11):3429–38.CrossRefGoogle Scholar
Karandikar YS, Chaudhari SR, Dalal NP, Sharma M, Pandit VA. Inappropriate prescribing in the elderly: a comparison of two validated screening tools. J Clin Gerontol Geriatr. 2013;4(4):109–14.CrossRefGoogle Scholar
Pradhan S, Panda A, Mohanty M, Behera JP, Ramani YR, Pradhan PK. A study of the prevalence of potentially inappropriate medication in elderly in a tertiary care teaching hospital in the state of Odisha. Int J Med Public Health. 2015;5:344–8.CrossRefGoogle Scholar
Kondo N, Nakamura F, Yamazaki S, Yamamoto Y, Akizawa T, Akiba T, et al. Prescription of potentially inappropriate medications to elderly hemodialysis patients: prevalence and predictors. Nephrol Dial Transplant. 2015;30:498–505.CrossRefGoogle Scholar
Lutz BH, Miranda VIA, Bertoldi AD. Potentially inappropriate medications among older adults in Pelotas, Southern Brazil. Rev Saúde Pública. 2017;51:52.CrossRefGoogle Scholar
Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.Google Scholar
Keith SW, Maio V, Dudash K, Templin M, Del Canale S. A physician-focused intervention to reduce potentially inappropriate medication prescribing in older people. Drugs Aging. 2013;30(2):119–27.CrossRefGoogle Scholar
Scott IA, Pillans PI, Barras M, Morris C. Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Ther Adv Drug Saf. 2018;9(9):559–73.CrossRefGoogle Scholar